PF-4942847
PF-4942847 is a novel, orally bioavailable Hsp90 inhibitor under investigation for triple-negative breast cancer (TNBC) due to its synergistic disruption of multiple oncogenic pathways. Its mechanism, demonstrated in vitro and in vivo, includes inducing AKT degradation in peripheral blood lymphocytes, a potential pharmacodynamic biomarker for clinical trials.
Product Specifications
CAS Number
1046859-34-0
Smiles
O=C (NCC (F) (F) F) N1CC=2N=C (N=C (C=3C (Cl) =CC (Cl) =CC3OCCN4N=CC=C4) C2C1) N
Molecular Formula
C20H18Cl2F3N7O2
Molecular Weight
516.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E0968Ra-01 48 Well
Rat Angiotensin converting enzyme 2, ACE2 ELISA KIT
Sign In for Pricing
View Details E0968Ra-02 96 Well
Rat Angiotensin converting enzyme 2, ACE2 ELISA KIT
Sign In for Pricing
View Details E0968Ra-03 5x 96 Tests
Rat Angiotensin converting enzyme 2, ACE2 ELISA KIT
Sign In for Pricing
View Details E0968Ra-04 10x 96 Tests
Rat Angiotensin converting enzyme 2, ACE2 ELISA KIT
Sign In for Pricing
View Details 
RC217545L4V 200 µL
HAUS5 (NM_015302) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details